Heron Therapeutics Inc
NASDAQ:HRTX
Income Statement
Earnings Waterfall
Heron Therapeutics Inc
Revenue
|
132.1m
USD
|
Cost of Revenue
|
-56.7m
USD
|
Gross Profit
|
75.4m
USD
|
Operating Expenses
|
-157.8m
USD
|
Operating Income
|
-82.3m
USD
|
Other Expenses
|
1.4m
USD
|
Net Income
|
-81m
USD
|
Income Statement
Heron Therapeutics Inc
Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
5
+278%
|
13
+173%
|
22
+64%
|
31
+40%
|
39
+26%
|
47
+23%
|
59
+24%
|
78
+32%
|
98
+26%
|
117
+20%
|
140
+20%
|
146
+4%
|
140
-4%
|
126
-10%
|
103
-18%
|
89
-14%
|
83
-6%
|
83
0%
|
86
+4%
|
86
N/A
|
90
+4%
|
95
+6%
|
98
+4%
|
108
+10%
|
114
+6%
|
118
+4%
|
123
+4%
|
127
+3%
|
132
+4%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
(3)
|
(5)
|
(7)
|
(11)
|
(17)
|
(28)
|
(39)
|
(48)
|
(57)
|
(62)
|
(57)
|
(53)
|
(43)
|
(36)
|
(35)
|
(40)
|
(44)
|
(46)
|
(48)
|
(50)
|
(53)
|
(55)
|
(60)
|
(64)
|
(68)
|
(65)
|
(57)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
4
+208%
|
11
+203%
|
19
+67%
|
26
+40%
|
32
+23%
|
37
+14%
|
41
+13%
|
50
+21%
|
58
+16%
|
69
+19%
|
82
+19%
|
84
+2%
|
82
-2%
|
73
-11%
|
60
-17%
|
52
-13%
|
48
-7%
|
43
-12%
|
42
-2%
|
40
-4%
|
42
+3%
|
45
+9%
|
45
0%
|
53
+17%
|
53
+1%
|
54
+0%
|
55
+3%
|
62
+13%
|
75
+22%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(59)
|
(63)
|
(69)
|
(75)
|
(78)
|
(82)
|
(85)
|
(97)
|
(110)
|
(130)
|
(155)
|
(172)
|
(191)
|
(197)
|
(198)
|
(221)
|
(229)
|
(231)
|
(236)
|
(234)
|
(255)
|
(279)
|
(285)
|
(295)
|
(281)
|
(276)
|
(287)
|
(281)
|
(276)
|
(275)
|
(267)
|
(258)
|
(270)
|
(263)
|
(253)
|
(227)
|
(198)
|
(191)
|
(176)
|
(173)
|
(158)
|
|
Selling, General & Administrative |
(22)
|
(22)
|
(20)
|
(20)
|
(20)
|
(23)
|
(27)
|
(36)
|
(47)
|
(56)
|
(65)
|
(69)
|
(70)
|
(75)
|
(78)
|
(82)
|
(85)
|
(84)
|
(88)
|
(94)
|
(111)
|
(124)
|
(126)
|
(128)
|
(120)
|
(112)
|
(108)
|
(106)
|
(100)
|
(108)
|
(121)
|
(127)
|
(135)
|
(134)
|
(128)
|
(120)
|
(119)
|
(123)
|
(120)
|
(117)
|
(111)
|
|
Research & Development |
(37)
|
(41)
|
(49)
|
(55)
|
(57)
|
(59)
|
(59)
|
(61)
|
(63)
|
(74)
|
(90)
|
(103)
|
(120)
|
(122)
|
(120)
|
(139)
|
(145)
|
(146)
|
(148)
|
(140)
|
(143)
|
(155)
|
(159)
|
(167)
|
(161)
|
(164)
|
(178)
|
(175)
|
(176)
|
(167)
|
(146)
|
(131)
|
(135)
|
(128)
|
(125)
|
(108)
|
(79)
|
(68)
|
(56)
|
(56)
|
(47)
|
|
Operating Income |
(59)
N/A
|
(63)
-6%
|
(69)
-10%
|
(75)
-8%
|
(78)
-4%
|
(82)
-5%
|
(85)
-4%
|
(97)
-14%
|
(110)
-13%
|
(130)
-18%
|
(155)
-19%
|
(171)
-10%
|
(187)
-9%
|
(186)
+1%
|
(179)
+3%
|
(195)
-8%
|
(197)
-1%
|
(194)
+2%
|
(195)
0%
|
(184)
+5%
|
(197)
-7%
|
(210)
-7%
|
(203)
+3%
|
(211)
-4%
|
(199)
+6%
|
(203)
-2%
|
(226)
-12%
|
(228)
-1%
|
(228)
+0%
|
(232)
-2%
|
(226)
+3%
|
(218)
+3%
|
(229)
-5%
|
(218)
+5%
|
(208)
+5%
|
(175)
+16%
|
(145)
+17%
|
(138)
+5%
|
(121)
+12%
|
(111)
+8%
|
(82)
+26%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(1)
|
0
|
(1)
|
(1)
|
(1)
|
0
|
0
|
(1)
|
(1)
|
(1)
|
0
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
6
|
1
|
2
|
2
|
2
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
|
Total Other Income |
0
|
(0)
|
0
|
(1)
|
0
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
3
|
2
|
7
|
8
|
6
|
0
|
4
|
3
|
0
|
(1)
|
(1)
|
(2)
|
(3)
|
(1)
|
(1)
|
(8)
|
(7)
|
(7)
|
(6)
|
1
|
1
|
1
|
1
|
|
Pre-Tax Income |
(60)
N/A
|
(63)
-6%
|
(70)
-10%
|
(76)
-9%
|
(79)
-4%
|
(83)
-5%
|
(87)
-4%
|
(98)
-12%
|
(110)
-13%
|
(131)
-18%
|
(156)
-20%
|
(173)
-11%
|
(190)
-10%
|
(190)
+0%
|
(183)
+4%
|
(198)
-8%
|
(199)
-1%
|
(195)
+2%
|
(192)
+2%
|
(179)
+7%
|
(190)
-6%
|
(201)
-6%
|
(196)
+2%
|
(205)
-4%
|
(193)
+6%
|
(198)
-3%
|
(223)
-12%
|
(227)
-2%
|
(228)
0%
|
(234)
-3%
|
(228)
+2%
|
(221)
+3%
|
(232)
-5%
|
(227)
+2%
|
(217)
+5%
|
(182)
+16%
|
(151)
+17%
|
(137)
+9%
|
(120)
+12%
|
(111)
+8%
|
(81)
+27%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(60)
|
(63)
|
(70)
|
(76)
|
(79)
|
(83)
|
(87)
|
(98)
|
(110)
|
(131)
|
(156)
|
(173)
|
(190)
|
(190)
|
(183)
|
(198)
|
(199)
|
(195)
|
(192)
|
(179)
|
(190)
|
(201)
|
(196)
|
(205)
|
(193)
|
(198)
|
(223)
|
(227)
|
(228)
|
(234)
|
(228)
|
(221)
|
(232)
|
(227)
|
(217)
|
(182)
|
(151)
|
(137)
|
(120)
|
(111)
|
(81)
|
|
Net Income (Common) |
(60)
N/A
|
(63)
-6%
|
(70)
-10%
|
(76)
-9%
|
(79)
-4%
|
(83)
-5%
|
(87)
-4%
|
(98)
-12%
|
(110)
-13%
|
(131)
-18%
|
(156)
-20%
|
(173)
-11%
|
(190)
-10%
|
(190)
+0%
|
(183)
+4%
|
(198)
-8%
|
(199)
-1%
|
(195)
+2%
|
(192)
+2%
|
(179)
+7%
|
(190)
-6%
|
(201)
-6%
|
(196)
+2%
|
(205)
-4%
|
(193)
+6%
|
(198)
-3%
|
(223)
-12%
|
(227)
-2%
|
(228)
0%
|
(234)
-3%
|
(228)
+2%
|
(221)
+3%
|
(232)
-5%
|
(227)
+2%
|
(217)
+5%
|
(182)
+16%
|
(151)
+17%
|
(137)
+9%
|
(120)
+12%
|
(111)
+8%
|
(81)
+27%
|
|
EPS (Diluted) |
-2.52
N/A
|
-2.61
-4%
|
-2.4
+8%
|
-2.87
-20%
|
-2.7
+6%
|
-2.68
+1%
|
-2.43
+9%
|
-2.95
-21%
|
-3.04
-3%
|
-3.52
-16%
|
-3.99
-13%
|
-4.57
-15%
|
-3.76
+18%
|
-3.52
+6%
|
-3.37
+4%
|
-3.65
-8%
|
-3.08
+16%
|
-2.71
+12%
|
-2.46
+9%
|
-2.44
+1%
|
-2.41
+1%
|
-2.52
-5%
|
-2.45
+3%
|
-2.5
-2%
|
-2.13
+15%
|
-2.18
-2%
|
-2.47
-13%
|
-2.5
-1%
|
-2.51
0%
|
-2.37
+6%
|
-2.24
+5%
|
-2.24
N/A
|
-2.27
-1%
|
-2.23
+2%
|
-1.94
+13%
|
-1.67
+14%
|
-1.26
+25%
|
-1.14
+10%
|
-0.82
+28%
|
-0.8
+2%
|
-0.53
+34%
|